/
Metabolic & Endocrine
405Diseases↗
4.1KPipeline Programs↗
1.9KActive Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
8,649
clinical trials
Completed5,309 · 61%
Recruiting943 · 11%
Unknown status684 · 8%
Terminated526 · 6%
Not yet recruiting449 · 5%
Active, not recruiting385 · 4%
Other353 · 4%
Competitive
Top Companies Companies ranked by number of pipeline programs they run in this therapeutic area.
108programs
100programs
93programs
88programs
87programs
Landscape
Diseases
Type 2 Diabetes
Most programs710
Programs
303
Trials
102
Recruiting
Pre
121
P1
117
P2
207
P3
206
Appr
251
Most programs:
Eli Lilly
Eli LillyType 2 Diabetes Mellitus
Most trials579
Programs
255
Trials
36
Recruiting
Pre
75
P1
117
P2
174
P3
161
Appr
162
Most programs:
Sanofi
SanofiDiabetes
Highest activity0
Programs
542
Trials
29
Recruiting
Pre
1
P1
2
P2
1
P3
—
Appr
2
Most programs:
Chiesi Farmaceutici S.p.A.
Chiesi Farmaceutici S.p.A.Type 1 Diabetes
9302 programs138 trialsApproved
Diabetes Mellitus
5238 programs131 trialsApproved
Type 1 Diabetes Mellitus
5207 programs124 trialsApproved
Metabolic Syndrome
2161 programs21 trialsApproved
Diabetic Foot
1148 programs31 trialsApproved
Polycystic Ovary Syndrome
2140 programs20 trialsApproved
Insulin Resistance
4136 programs18 trialsApproved
Hypercholesterolemia
2105 programs33 trialsApproved
Non-Alcoholic Steatohepatitis
85 programs38 trialsApproved
Hyperlipidemia
181 programs11 trialsApproved
Hypoglycemia
165 programs9 trialsApproved
Hypertriglyceridemia
155 programs15 trialsApproved
Hyperglycemia
58 programs7 trialsApproved
Growth Hormone Deficiency
148 programs14 trialsApproved
Gestational Diabetes
343 programs17 trialsApproved
Obesity or Overweight
40 programs58 trialsPhase 3
Morbid Obesity
153 programs2 trialsApproved
Familial Hypercholesterolemia
37 programs18 trialsApproved
Prader-Willi Syndrome
242 programs11 trialsApproved
Hypothyroidism
235 programs17 trialsApproved
Hyperuricemia
39 programs8 trialsApproved
Hypoparathyroidism
332 programs13 trialsApproved
Mucopolysaccharidosis
133 programs11 trialsApproved
Hypogonadism
36 programs4 trialsApproved
Overweight or Obesity
10 programs40 trialsPhase 2
Secondary Hyperparathyroidism
133 programs5 trialsApproved
Congenital Adrenal Hyperplasia
227 programs8 trialsApproved
Showing top 30 diseases by activity. 375 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)